3M CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that 3M CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.95B | Feb 3, 2026 |
| FY2024 | Dec 31, 2024 | $6.01B | Feb 5, 2025 |
| FY2024 | Sep 30, 2024 | $6.29B | Feb 5, 2025 |
| FY2024 | Jun 30, 2024 | $6.26B | Feb 5, 2025 |
| FY2024 | Mar 31, 2024 | $6.02B | Feb 5, 2025 |
| FY2024 | Dec 31, 2023 | $6.00B | Feb 5, 2025 |
| FY2024 | Sep 30, 2023 | $6.27B | Feb 5, 2025 |
| FY2024 | Jun 30, 2023 | $6.28B | Feb 5, 2025 |
| FY2024 | Mar 31, 2023 | $6.06B | Feb 5, 2025 |
| FY2024 | Dec 31, 2022 | $26.16B | Feb 5, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.95B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $24.58B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $24.61B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $26.16B | Feb 5, 2025 |
| FY2022 | Dec 31, 2021 | $35.36B | Feb 8, 2023 |
| FY2020 | Dec 31, 2020 | $8.58B | Feb 4, 2021 |
| FY2020 | Sep 30, 2020 | $8.35B | Feb 4, 2021 |
| FY2020 | Jun 30, 2020 | $7.18B | Feb 4, 2021 |
| FY2020 | Mar 31, 2020 | $8.08B | Feb 4, 2021 |
| FY2020 | Dec 31, 2019 | $8.11B | Feb 4, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $7.99B | Feb 8, 2018 |
| FY2017 | Sep 30, 2017 | $8.17B | Feb 8, 2018 |
| FY2017 | Jun 30, 2017 | $7.81B | Feb 8, 2018 |
| FY2017 | Mar 31, 2017 | $7.69B | Feb 8, 2018 |
| FY2016 | Dec 31, 2016 | $7.33B | Feb 9, 2017 |
| FY2016 | Sep 30, 2016 | $7.71B | Feb 9, 2017 |
| FY2016 | Jun 30, 2016 | $7.66B | Feb 9, 2017 |
| FY2016 | Mar 31, 2016 | $7.41B | Feb 9, 2017 |
| FY2015 | Dec 31, 2015 | $7.30B | Feb 11, 2016 |
| FY2015 | Sep 30, 2015 | $7.71B | Feb 11, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.25B | Feb 3, 2026 |
| FY2024 | Dec 31, 2024 | $728.00M | Feb 5, 2025 |
| FY2024 | Sep 30, 2024 | $1.37B | Feb 5, 2025 |
| FY2024 | Jun 30, 2024 | $1.15B | Feb 5, 2025 |
| FY2024 | Mar 31, 2024 | $928.00M | Feb 5, 2025 |
| FY2024 | Dec 31, 2023 | $945.00M | Feb 5, 2025 |
| FY2024 | Sep 30, 2023 | ($2.08B) | Feb 5, 2025 |
| FY2024 | Jun 30, 2023 | ($6.84B) | Feb 5, 2025 |
| FY2024 | Mar 31, 2023 | $976.00M | Feb 5, 2025 |
| FY2024 | Dec 31, 2022 | $5.78B | Feb 5, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.63B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $4.82B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | ($10.69B) | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $4.37B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $7.37B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $7.16B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $6.17B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $7.21B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $7.69B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $7.03B | Feb 7, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $700.00M | Feb 5, 2025 |
| FY2024 | Dec 31, 2023 | $700.00M | Feb 5, 2025 |
| FY2024 | Dec 31, 2022 | $800.00M | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $1.20B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $1.10B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $1.25B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $1.25B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $1.35B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $1.25B | Feb 7, 2019 |
| FY2017 | Dec 31, 2015 | $1.22B | Feb 8, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.00B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $4.22B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $19.20B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $7.23B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $7.20B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $6.93B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $7.03B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $7.60B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $6.63B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $6.31B | Feb 7, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.31B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $1.82B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $6.68B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $5.59B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $7.45B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $8.11B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $7.07B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $6.44B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $6.24B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $6.66B | Feb 7, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $910.00M | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $1.62B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $1.75B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $1.60B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $1.50B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $1.70B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $1.58B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $1.37B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $1.42B | Feb 7, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.73B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $39.87B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $50.58B | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | $46.46B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $47.07B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $47.34B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $44.66B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $36.50B | Feb 6, 2020 |
| FY2019 | Dec 31, 2017 | $37.99B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $32.91B | Feb 7, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.99B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $35.97B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $45.71B | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | $31.69B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $31.96B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $34.41B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $34.53B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $26.65B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $26.37B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $22.56B | Feb 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.70B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $3.84B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $4.81B | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | $14.72B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $15.05B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $12.87B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $10.06B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $9.80B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $11.56B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $10.30B | Feb 8, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.42B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $6.28B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $6.38B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $6.34B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $13.49B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $13.80B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $13.44B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $10.05B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $10.51B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $9.17B | Feb 7, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.26B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $36.80B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $37.48B | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | $47.95B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $45.82B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $43.82B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $42.14B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $40.64B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $39.12B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $37.91B | Feb 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $2.40B | Feb 9, 2017 |
| FY2015 | Dec 31, 2015 | $1.80B | Feb 11, 2016 |
| FY2014 | Dec 31, 2014 | $1.90B | Feb 12, 2015 |
| FY2013 | Dec 31, 2013 | $2.58B | Feb 13, 2014 |
| FY2012 | Dec 31, 2012 | $2.88B | Feb 14, 2013 |
| FY2011 | Dec 31, 2011 | $2.22B | Feb 16, 2012 |
| FY2010 | Dec 31, 2010 | $3.38B | Feb 16, 2011 |
| FY2009 | Dec 31, 2009 | $3.04B | Feb 16, 2010 |
| FY2009 | Dec 31, 2008 | $1.85B | Feb 16, 2010 |
| FY2009 | Dec 31, 2007 | $1.90B | Feb 16, 2010 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.60B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $13.04B | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | $14.24B | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | $15.94B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $17.35B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $18.78B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $19.36B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $14.16B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $13.20B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $11.48B | Feb 8, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 3, 2026 |
| FY2024 | Dec 31, 2024 | 1 | Feb 5, 2025 |
| FY2024 | Sep 30, 2024 | 2 | Feb 5, 2025 |
| FY2024 | Jun 30, 2024 | 2 | Feb 5, 2025 |
| FY2024 | Mar 31, 2024 | 1 | Feb 5, 2025 |
| FY2024 | Dec 31, 2023 | 1 | Feb 5, 2025 |
| FY2024 | Sep 30, 2023 | (3) | Feb 5, 2025 |
| FY2024 | Jun 30, 2023 | (12) | Feb 5, 2025 |
| FY2024 | Mar 31, 2023 | 1 | Feb 5, 2025 |
| FY2024 | Dec 31, 2022 | 10 | Feb 5, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 3, 2026 |
| FY2024 | Dec 31, 2024 | 1 | Feb 5, 2025 |
| FY2024 | Sep 30, 2024 | 2 | Feb 5, 2025 |
| FY2024 | Jun 30, 2024 | 2 | Feb 5, 2025 |
| FY2024 | Mar 31, 2024 | 1 | Feb 5, 2025 |
| FY2024 | Dec 31, 2023 | 1 | Feb 5, 2025 |
| FY2024 | Sep 30, 2023 | (3) | Feb 5, 2025 |
| FY2024 | Jun 30, 2023 | (12) | Feb 5, 2025 |
| FY2024 | Mar 31, 2023 | 1 | Feb 5, 2025 |
| FY2024 | Dec 31, 2022 | 10 | Feb 5, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 530.28M | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | 539.47M | Feb 3, 2026 |
| FY2024 | Dec 31, 2023 | 552.58M | Feb 5, 2025 |
| FY2023 | Dec 31, 2022 | 549.25M | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | 571.85M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | 577.75M | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | 575.18M | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | 576.58M | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | 594.88M | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | 596.73M | Feb 8, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.56B | Feb 3, 2026 |
| FY2025 | Dec 31, 2024 | $1.98B | Feb 3, 2026 |
| FY2025 | Dec 31, 2023 | $3.31B | Feb 3, 2026 |
| FY2024 | Dec 31, 2022 | $3.37B | Feb 5, 2025 |
| FY2023 | Dec 31, 2021 | $3.42B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $3.39B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $3.32B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $3.19B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $2.80B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $2.68B | Feb 7, 2019 |